Fibrosis Progression and Incidence of Cirrhosis and Hepatic Decompensation in Persons Treated with Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir: Results from ERCHIVES

av Simon, Tracey, Yan, Peng, Kort, Jens, Butt, Adeel
I publikationen Open Forum Infect Dis (2017)

No Clinically Relevant Drug-Drug Interactions between Methadone or Buprenorphine-Naloxone and Antiviral Combination Glecaprevir and Pibrentasvir

av Kosloski, Matthew P., Zhao, Weihan, Asatryan, Armen, Kort, Jens, Geoffroy, Pierre, Liu, Wei
I publikationen Antimicrob Agents Chemother (2017)

Effects of Tipranavir, Darunavir, and Ritonavir on Platelet Function, Coagulation, and Fibrinolysis in Healthy Volunteers

av Kort, Jens J, Aslanyan, Stella, Scherer, Joseph, Sabo, John P, Kohlbrenner, Veronika, Robinson, Patrick
Publicerad 2011

High antiviral activity of NS5A inhibitor ABT‐530 with paritaprevir/ritonavir and ribavirin against hepatitis C virus genotype 3 infection

av Poordad, Fred, Landis, Charles S., Asatryan, Armen, Jackson, Daniel F., Ng, Teresa I., Fu, Bo, Lin, Chih‐Wei, Yao, Betty, Kort, Jens
I publikationen Liver Int (2016)

Effects of Renal Impairment and Hemodialysis on the Pharmacokinetics and Safety of the Glecaprevir and Pibrentasvir Combination in Hepatitis C Virus-Negative Subjects

av Kosloski, Matthew P., Zhao, Weihan, Marbury, Thomas C., Preston, Richard A., Collins, Michael G., Pugatch, David, Mensa, Federico, Kort, Jens, Liu, Wei
I publikationen Antimicrob Agents Chemother (2018)

Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients with Chronic Hepatitis C Infection

av Flamm, Steven L., Kort, Jens, Marx, Steven E., Strezewski, John, Dylla, Douglas E., Bacon, Bruce, Curry, Michael P., Tsai, Naoky, Wick, Nicole
I publikationen Adv Ther (2020)

Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection

av Lawitz, Eric J., O'Riordan, William D., Asatryan, Armen, Freilich, Bradley L., Box, Terry D., Overcash, J. Scott, Lovell, Sandra, Ng, Teresa I., Liu, Wei, Campbell, Andrew, Lin, Chih-Wei, Yao, Betty, Kort, Jens
I publikationen Antimicrob Agents Chemother (2016)

Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection

av Ng, Teresa I., Pilot-Matias, Tami, Tripathi, Rakesh, Schnell, Gretja, Krishnan, Preethi, Reisch, Thomas, Beyer, Jill, Dekhtyar, Tatyana, Irvin, Michelle, Lu, Liangjun, Asatryan, Armen, Campbell, Andrew, Yao, Betty, Lovell, Sandra, Mensa, Federico, Lawitz, Eric J., Kort, Jens, Collins, Christine
I publikationen Viruses (2018)

Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment

av Poordad, Fred, Felizarta, Franco, Asatryan, Armen, Sulkowski, Mark S., Reindollar, Robert W., Landis, Charles S., Gordon, Stuart C., Flamm, Steven L., Fried, Michael W., Bernstein, David E., Lin, Chih‐Wei, Liu, Ran, Lovell, Sandra S., Ng, Teresa I., Kort, Jens, Mensa, Federico J.
I publikationen Hepatology (2017)

Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial

av Wyles, David, Poordad, Fred, Wang, Stanley, Alric, Laurent, Felizarta, Franco, Kwo, Paul Y., Maliakkal, Benedict, Agarwal, Kosh, Hassanein, Tarek, Weilert, Frank, Lee, Samuel S., Kort, Jens, Lovell, Sandra S., Liu, Ran, Lin, Chih‐Wei, Pilot‐Matias, Tami, Krishnan, Preethi, Mensa, Federico J.
I publikationen Hepatology (2018)

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure

av Poordad, Fred, Pol, Stanislas, Asatryan, Armen, Buti, Maria, Shaw, David, Hézode, Christophe, Felizarta, Franco, Reindollar, Robert W., Gordon, Stuart C., Pianko, Stephen, Fried, Michael W., Bernstein, David E., Gallant, Joel, Lin, Chih‐Wei, Lei, Yang, Ng, Teresa I., Krishnan, Preethi, Kopecky‐Bromberg, Sarah, Kort, Jens, Mensa, Federico J.
I publikationen Hepatology (2018)

Multicenter Study to Transplant Hepatitis C–Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from...

av Sise, Meghan E., Goldberg, David S., Kort, Jens J., Schaubel, Douglas E., Alloway, Rita R., Durand, Christine M., Fontana, Robert J., Brown, Robert S., Friedewald, John J., Prenner, Stacey, Landis, J. Richard, Fernando, Melissa, Phillips, Caitlin C., Woodle, E. Steve, Rike-Shields, Adele, Sherman, Kenneth E., Elias, Nahel, Williams, Winfred W., Gustafson, Jenna L., Desai, Niraj M., Barnaba, Brittany, Norman, Silas P., Doshi, Mona, Sultan, Samuel T., Aull, Meredith J., Levitsky, Josh, Belshe, Dianne S., Chung, Raymond T., Reese, Peter P.
I publikationen J Am Soc Nephrol (2020)